PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Oliver Ottmann Martin Ruthardt Afsar Mian |
| Publication date | November 14, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |